BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3765416)

  • 1. [Preparation of leukocyte and thrombocyte concentrates using the Haemonetics model 30 blood cell separator].
    Fehérvízyová E; Hrubisko M; Danihelová E; Sviteková K
    Vnitr Lek; 1986 Aug; 32(8):784-9. PubMed ID: 3765416
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of the Fenwal CS-3000 automatic blood cell separator for cytopheresis (review)].
    Fiala J
    Vnitr Lek; 1986 Feb; 32(2):173-9. PubMed ID: 3962198
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of the isoradial chamber in the preparation of thrombocyte concentrates using the Travenol CS-3000 separator].
    Bláha M; Jebavý L; Malý J; Siroký O
    Cas Lek Cesk; 1989 Oct; 128(42):1336-7. PubMed ID: 2598246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombocyte aggregate formation during thrombocyte concentrate preparation with the CS-3000 Cell Separator (Fenwal) and its effects on the analysis of the concentrate with the Coulter Counter S Plus IV].
    Wassmann A; Aulmann HM; Stangel W; Meinicke K
    Beitr Infusionther Klin Ernahr; 1987; 18():216-8. PubMed ID: 3439976
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thrombocyte collection with the cell separator. Determination of status and perspectives].
    Müller V; Borberg H
    Beitr Infusionther Klin Ernahr; 1986; 15():58-65. PubMed ID: 3753414
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thrombocyte function in vitro using the Fenwal CS-3000 and Haemonetics V50 cell separators].
    Kretschmer V; Ulrich W; Grass H; Heinrich D
    Beitr Infusionther Klin Ernahr; 1986; 15():82-92. PubMed ID: 3753416
    [No Abstract]   [Full Text] [Related]  

  • 7. [Particle formation in disposable systems for the V.50.1 (Haemonetics) cell separator].
    Misterek J; Mueller-Eckhardt C
    Beitr Infusionsther; 1991; 28():159-61. PubMed ID: 1725614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation of leukocyte-poor thrombocyte concentrates from buffy coat by using a new quadruple bag system].
    Misterek J; Müller K; Bux J; Mueller-Eckhardt C
    Beitr Infusionsther; 1990; 26():96-8. PubMed ID: 1703911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor hemapheresis in France at the start of 1992.
    Coffe C; Norol F
    Transfus Sci; 1993 Apr; 14(2):163-4. PubMed ID: 10150147
    [No Abstract]   [Full Text] [Related]  

  • 10. [The safety of apparative cytapheresis].
    Böhm R; Borberg H
    Infusionsther Klin Ernahr; 1987 Sep; 14 Suppl 4():18-27. PubMed ID: 3679527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychophysiological thrombocyte changes in cell-separator donors].
    Aulmann HM; Baltrusch HJ; Stangel W; Waltz EM
    Beitr Infusionther Klin Ernahr; 1987; 18():227-9. PubMed ID: 3439979
    [No Abstract]   [Full Text] [Related]  

  • 12. Storage of haemonetics V50 derived platelets for five days.
    Rock G; Senack E; Tittley P
    Prog Clin Biol Res; 1990; 337():1-5. PubMed ID: 2352966
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical use of Haemonetics 30 blood cell separator in transfusiology and other fields of medicine.
    Daszyński J
    Acta Med Pol; 1980; 21(1):93-110. PubMed ID: 7405631
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thrombocyte yields and changes in laboratory indicators in thrombocytapheresis on the CS-3000 Separator].
    Pecka M; Bláha M; Malý J; Siroký O; Jebavý L; Zaydlar K; Vanásek J
    Vnitr Lek; 1988 May; 34(5):432-40. PubMed ID: 3414026
    [No Abstract]   [Full Text] [Related]  

  • 15. [Initial results with the new cell separator AS 104].
    Kretschmer V; See A; Söhngen D; Bachem M; Kadar JG; Borberg H; Pelzer H; Zöfel P
    Beitr Infusionsther; 1988; 21():113-7. PubMed ID: 2462955
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of the centrifugation speed on the sedimentation behavior of thrombocytes in the CS-3000 Cell Separator (Fenwal)].
    Brauer H; Aulmann HM; Stangel W
    Beitr Infusionther Klin Ernahr; 1987; 18():219-22. PubMed ID: 3439977
    [No Abstract]   [Full Text] [Related]  

  • 17. [Particle formation in thrombocytapheresis with the cell separator V 50.1].
    Misterek J; Strübel G; Neppert J; Rust H; Mueller-Eckhardt C
    Beitr Infusionsther; 1988; 21():118-21. PubMed ID: 2462956
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison of the Haemonetics V50, Fenwal CS 3000 and IBM 2997 blood separators].
    Storek J; Vítek A; Sejkorová J; Kobylka P
    Cas Lek Cesk; 1989 Apr; 128(18):562-5. PubMed ID: 2736598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viability of 5-day apheresis platelets in a citrate-plasticized bag using a new cell separator.
    Simon TL; Moore RC; Sierra ER; Ferdinando B
    Prog Clin Biol Res; 1990; 337():11-3. PubMed ID: 2352969
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thrombocyte collection with the A3p program using the blood cell separator Haemonetics MCS 3p].
    Moog R; Müller N
    Infusionsther Transfusionsmed; 1996 Feb; 23(1):60. PubMed ID: 8653018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.